Get the Weekly Intelligence Brief — top committee picks every Sunday.
CBT · NYSE · STOCK

Cabot (CBT) Stock Analysis

Basic Materials Updated September 06, 2026
$81.50
52W $58.33 – $94.53
52/100
$4.21B
22.6
0.83
AI Committee Verdict
Watch
52/100
Conviction: Contested · 60% agreement · 5 analysts
+2.6%
-2.2%
1.22:1
Contested

Is CBT Bullish or Bearish?

Mixed. Innellis AI committee rates Cabot Corp (CBT) Watch with a composite score of 52/100 , based on 5 analysts with 60% agreement. Last updated September 06, 2026.

What Would Change This View

Upgrade to Buy
Requires a committee score of 60.0 — +7.83 from today. Applies on the first day at or above the line; upgrades are never dampened.
Downgrade to Reduce
Requires the score to fall below 40.0 — -12.17 from today. The band boundary is 45.0, but a one-step downgrade must clear a further margin first. A score oscillating around the line should not change the rating every night.

Executive Summary

The committee is genuinely divided. Macro Analyst sees a compelling case — vix regime is low -- calm backdrop supports risk-taking. Growth Analyst remains cautious — revenue declining -4.7% yoy -- this is not a growth story right now. This disagreement is itself the signal — the setup is not clean in either direction.

Bull & Bear Case

Bull Case
  • VIX regime is low -- calm backdrop supports risk-taking — Macro
Bear Case
  • Revenue declining -4.7% YoY -- this is not a growth story right now — Growth
  • EPS declining -53.7% YoY despite any revenue growth — Growth
  • MACD histogram negative -- bearish momentum — Technical
Both cases are generated from quantitative data signals, not qualitative or forward-looking judgement. They summarise what the numbers say today.
Price History (6M)

AI Investment Committee

Committee Consensus As of September 06, 2026
Overall Committee Score
52/100
Agreement
60%
Analysts
5
Conviction
Contested
Sector Rank
Top 94%
of 99 Basic Materials peers
Value Analyst neutral
58 / 100 · Moderate confidence
Fair value -- neither a bargain nor obviously overpriced
Growth Analyst bearish
18 / 100 · Moderate confidence
Growth story is weak, decelerating, or inconsistent
− Revenue declining -4.7% YoY -- this is not a growth story right now
Technical Analyst neutral
48 / 100 · High confidence
Mixed or range-bound price action
− MACD histogram negative -- bearish momentum
Macro Analyst bullish
80 / 100 · Low confidence
Macro backdrop is supportive of risk assets generally, and this name's beta works in its favor
+ VIX regime is low -- calm backdrop supports risk-taking
News Analyst neutral
58 / 100 · Low confidence
News flow is mixed or quiet -- no strong signal either way right now
Portfolio Manager neutral
45 / 100 · High confidence
Portfolio-level factors are mixed -- worth a deliberate sizing decision, not a default-size position
+ Portfolio position concentration is currently healthy
− Sector concentration is already high (HHI 2704.43)
Open Full Terminal →

Investment Thesis Evolution

Committee score moved marginally from 52.2 to 52.2.

Comparing 2026-09-05 to 2026-09-06 (1 day apart).

Technical Analysis

RSI (14)
37.6
Neutral
MACD Histogram
-0.287
Bearish Momentum
Trend Direction
Sideways
Weekly: Uptrend
Market Structure
Lh Ll
Support
$79.73
Resistance
$83.64
Bollinger %B
0.13
Inside Bands
Price vs Moving Averages
EMA 9
$82.68 Below
EMA 21
$84.19 Below
EMA 50
$85.27 Below
EMA 200
$80.99 Above

Fundamental Analysis

Valuation
84
Growth
50
Profitability
55
Financial Health
70
Cash Flow
70
Valuation
P/E Ratio 22.6×
P/B Ratio 2.62×
PEG Ratio -0.42
Dividend Yield 2.26%
52W High $94.53
52W Low $58.33
Quality & Growth
ROE 2135.5%
ROA 867.6%
Gross Margin 2289.5%
Operating Margin 1378.7%
Revenue Growth YoY
Debt / Equity 0.79
AI Fundamental Assessment
P/E ratio of 22.6 (inexpensive relative to a 15-40x range); Price-to-book of 2.6x; PEG ratio of -0.4 (under 1.0 suggests growth is undervalued relative to price); Return on equity of 21.4%; Return on assets of 8.7%; Net margin of 5.2%; Gross margin of 22.9%; Current ratio of 1.47 (tight short-term liquidity); Debt-to-equity of 0.79; Free cash flow per share is positive (5.45); Most recent quarter missed estimates by 0.4%; EPS growth roughly steady (+5.2% -> +3.7% QoQ); Average YoY EPS growth of -12.1%; Analyst estimates rising over recent quarters
Get the Full CBT Analysis
Interactive charts · Live committee votes · Trade plan · Paper trading · AI Q&A
Open in Terminal →
Weekly Intelligence Brief
Get the committee's top-scored stocks every Sunday.
Free · No spam · Unsubscribe anytime